Effect of sarpogrelate after endovascular treatment for femoropopliteal disease in patients treated with sarpogrelate
Not Applicable
- Conditions
- peripheral artery disease
- Registration Number
- JPRN-UMIN000006235
- Lead Sponsor
- Kokura Memorial Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 180
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with previous lower extremity bypass surgery, previous EVT in the femoropopliteal artery, acute onset limb ischemia, or severe lower extremity ischemic symptoms classified into Rutherford category 1 or 6
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method primary patency
- Secondary Outcome Measures
Name Time Method secondary patency target lesion revascularization (TLR) major adverse cardiovascular events(MACE include death, non-fatal NI, stroke,revascularization, maojor amputtion)